Not known Facts About zanubrutinib
No adverse consequences on embryo-fetal growth have been observed in Expecting rabbits addressed orally with doses around a hundred mg/kg/day elafibranor, which produced systemic exposures (merged AUC for elafibranor and GFT1007) over the period of organogenesis which were below the human exposure. Administration of three hundred mg/kg/day (3.“It